Biofil Chemicals & Pharmaceuticals Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
BIOFILCHEM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Biofil Chemicals & Pharmaceuticals has submitted a quarterly compliance certificate to BSE and NSE for the period ending 31 December 2025. The certificate, issued by the company's Registrar and Share Transfer Agent (Ankit Consultancy Pvt. Ltd.), confirms that all share certificates received for dematerialization during the quarter were properly processed and confirmed to the depositories. It also confirms that physical certificates were mutilated and cancelled, and the depositories' names were updated in the register of members within the required 15-day timeline. This is a standard regulatory compliance filing with no reference to any business or financial activity.
No material impact on shareholders or stock price. This is a routine quarterly compliance submission confirming proper handling of dematerialization requests by the company's registrar.